These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7917554)

  • 61. Immunohistology of oestrogen receptor and D5 antigen in breast cancer: correlation with oestrogen receptor content of adjacent cryostat sections assayed by radioligand binding and enzyme immunoassay.
    Giri DD; Dangerfield VJ; Lonsdale R; Rogers K; Underwood JC
    J Clin Pathol; 1987 Jul; 40(7):734-40. PubMed ID: 3305584
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Difference between analytical sensitivity and detection limit.
    Lozano D; Cantero M
    Am J Clin Pathol; 1997 May; 107(5):619-20. PubMed ID: 9128277
    [No Abstract]   [Full Text] [Related]  

  • 63. Influence of tamoxifen on the tumor content of steroid hormone receptors (ER, PgR and AR) in patients with primary breast cancer.
    Lundgren S; Søreide JA; Lea OA
    Anticancer Res; 1994; 14(3B):1313-6. PubMed ID: 8067700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. What information should manufacturers provide on their procedures?
    Bais R
    Clin Chem; 2006 Aug; 52(8):1624-5. PubMed ID: 16873314
    [No Abstract]   [Full Text] [Related]  

  • 65. [Determination of estradiol receptors by immunoenzyme technique and by radioligand binding in 2134 breast tumors].
    Romain S; Dussert C; Martin PM
    Bull Cancer; 1991; 78(4):331-40. PubMed ID: 1713518
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Use of the ProSpecT microplate enzyme immunoassay for the detection of pathogenic and non-pathogenic Entamoeba histolytica in faecal specimens.
    Ong SJ; Cheng MY; Liu KH; Horng CB
    Trans R Soc Trop Med Hyg; 1996; 90(3):248-9. PubMed ID: 8758065
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The performance of a commercial radioligand binding assay for the epidermal growth factor receptor is comparable to the EORTC standard assay.
    Oberkanins C; Geurts-Moespot A; Zeillinger R; Kury F; Leake RE; Benraad TJ
    Eur J Cancer; 1995 Sep; 31A(10):1710-1. PubMed ID: 7488430
    [No Abstract]   [Full Text] [Related]  

  • 68. How best to express oestrogen receptor activity.
    Hawkins RA
    Br J Cancer; 1996 Nov; 74(9):1329-30. PubMed ID: 8912524
    [No Abstract]   [Full Text] [Related]  

  • 69. Quantitative analysis of c-erbB-2 protein in breast cancer tissue by enzyme immunoassay.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    Jpn J Clin Oncol; 1994 Apr; 24(2):74-8. PubMed ID: 7908994
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immunoassay method validation for a modified EMIT phencyclidine assay.
    Cary PL; Johnson CA; Folsom TM; Bales WR
    J Anal Toxicol; 1992; 16(1):48-51. PubMed ID: 1640698
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Clinical and methodological considerations in the quantification of estrogen and progesterone receptors using monoclonal antibodies in breast cancer].
    Navarro MA; Huguet J; Valero J; Samaniego JM; Rosel P; Sirvent JJ
    Med Clin (Barc); 1991 Jun; 97(2):41-4. PubMed ID: 1895780
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Studies on chemical analysis of mycotoxin (XIX). Enzyme immunoassay of T-2 toxin in foods].
    Isohata E; Toyoda M; Saito Y
    Eisei Shikenjo Hokoku; 1988; (106):117-20. PubMed ID: 3074846
    [No Abstract]   [Full Text] [Related]  

  • 73. Calmodulin levels in oestrogen receptor positive and negative human breast tumours.
    Krishnaraju K; Murugesan K; Vij U; Kapur BM; Farooq A
    Br J Cancer; 1991 Mar; 63(3):346-7. PubMed ID: 2003974
    [No Abstract]   [Full Text] [Related]  

  • 74. Semiquantitative oestrogen receptor assay in formalin-fixed paraffin sections of human breast cancer tissue using monoclonal antibodies.
    Andersen J; Orntoft T; Poulsen HS
    Br J Cancer; 1986 May; 53(5):691-4. PubMed ID: 3521693
    [No Abstract]   [Full Text] [Related]  

  • 75. [The actual issues of comparing the results of quantitative immune-enzyme tests].
    PKuvshinov MV; Obriadina AP
    Klin Lab Diagn; 2012 Apr; (4):32-5. PubMed ID: 22768715
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An ultrasensitive immunoassay for human IgE measurement in cell-culture supernatant.
    Vasilov RG; Tsitsikov EN
    Immunol Lett; 1990 Dec; 26(3):283-4. PubMed ID: 2086457
    [No Abstract]   [Full Text] [Related]  

  • 77. Enzyme immunoassays in clinical chemistry: present status and trends.
    Oellerich M
    J Clin Chem Clin Biochem; 1980 Apr; 18(4):197-208. PubMed ID: 6770030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Commercial immunoassays in biomarkers studies: researchers beware!
    Rifai N; Watson ID; Miller WG
    Clin Chem; 2012 Oct; 58(10):1387-8. PubMed ID: 22791886
    [No Abstract]   [Full Text] [Related]  

  • 79. A comparative study of manual methods for serum triglyeride estimation.
    Goldfinch ME; Prudhoe K
    Ann Clin Biochem; 1975 Jan; 12(1):9-13. PubMed ID: 15637931
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Calibration of prolactin kits.
    Hall CA; Lojewski RJ
    Clin Chem; 1985 Jun; 31(6):1100-1. PubMed ID: 3995756
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.